Solventum Q1 FY26 GAAP EPS swings to $0.07; sales fall 3% to $2 billion

Solventum Corporation

Solventum Corporation

SOLV

0.00
  • Solventum posted Q1 sales of $2 billion, down 3% on a reported basis, while organic sales growth rose 2.1%.
  • Diluted GAAP EPS came in at $0.07; adjusted diluted EPS rose to $1.48.
  • Operating cash flow swung to an outflow of $189 million.
  • Guidance calls for 2026 organic sales growth of 2% to 3% and adjusted diluted EPS of $6.40 to $6.60, with free cash flow around $200 million.
  • Management highlighted portfolio moves including divestiture of Purification & Filtration and acquisition of Acera Surgical, while launching share repurchases under a $1 billion authorization.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Solventum Corporation published the original content used to generate this news brief on May 06, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.